col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


53 Results       Page 1

 [1] 
Springer-Verlag: Advances in Therapy
  original article Date Title Authors   All Authors
1 [GO] 2025―May―08 Therapeutic Approaches for COVID-19: A Review of Antiviral Treatments, Immunotherapies, and Emerging Interventions Maria C. S. Alves, Ruana C. C. da Silva, Sérgio S. P. de Leitão-Júnior, Valdir Q. de Balbino
2 [GO] 2025―Mar―10 Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE Xuan Wang, Ankit Pahwa, Mary T. Bausch-Jurken, Anushri Chitkara, Pawana Sharma, Mia Malmenäs, et al. (+9)
3 [GO] 2025―Feb―10 Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands Florian Zeevat, Simon van der Pol, Tjalke Westra, Ekkehard Beck, Maarten J. Postma, Cornelis Boersma
4 [GO] 2025―Jan―15 Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19 Michael Dreher, Hanna-Teresa Heier, Andrea Kienle-Gogolok, Kristina Röschmann-Doose, Jörg Simon, Ravi Singhal, et al. (+6)
5 [GO] 2024―Dec―16 Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals Christoph D. Spinner, Samira Bell, Hermann Einsele, Cécile Tremblay, Michel Goldman, Zain Chagla, et al. (+17)
6 [GO] 2024―Jan―13 Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study Amita Ketkar, Vincent Willey, Lisa Glasser, Casey Dobie, Cachet Wenziger, Chia-Chen Teng, et al. (+4)
7 [GO] 2023―Dec―04 The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey Laurent Peyrin-Biroulet, Karoliina Ylänne, Allyson Sipes, Michelle Segovia, Sean Gardiner, Joseph C. Cappelleri, et al. (+2)
8 [GO] 2023―Nov―27 Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities Wang-Da Liu, Hsin-An Hou, Ko-Jen Li, Albert Qin, Chan-Yen Tsai, Wang-Huei Sheng
9 [GO] 2023―Aug―24 Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Daniel Q. Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Wesley K. Thompson, et al. (+23)
10 [GO] 2023―Jul―01 Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients Pierre Pommerolle, Pierre Laurent, Claire Presne, François Brazier, Maïté Jaureguy, Coralie Poulain, et al. (+5)
11 [GO] 2023―Jun―22 Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 Thomas Bieber, Eugen Feist, Alan D. Irvine, Masayoshi Harigai, Ewa Haladyj, Susan Ball, et al. (+4)
12 [GO] 2023―Jun―20 Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States Yizhou Ye, Xiaomeng Yue, Whitney S. Krueger, Lani R. Wegrzyn, Anna W. Maniccia, Kevin L. Winthrop, Seoyoung C. Kim
13 [GO] 2023―Jun―12 Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, Shinzo Hiroi, Kosuke Iwasaki, Tomomi Takeshima, et al. (+2)
14 [GO] 2022―Sep―25 Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States Xiaomeng Yue, Yizhou Ye, Yookyung C. Choi, Dongmu Zhang, Whitney S. Krueger
15 [GO] 2022―Sep―17 Experience on the Management of Patients with Asthma or Chronic Obstructive Pulmonary Disease During the COVID-19 Pandemic: the NEUMOBIAL Study Pedro Landete, Jose Ignacio Prieto Romo, Fernando Giacomini
16 [GO] 2022―Sep―05 A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 Thomas Bieber, Eugen Feist, Alan D. Irvine, Masayoshi Harigai, Ewa Haladyj, Susan Ball, et al. (+4)
17 [GO] 2022―Aug―12 Comparative Effectiveness of Dexamethasone in Hospitalized COVID-19 Patients in the United States Casey Kar-Chan Choong, Mark Belger, Alisa E. Koch, Kristin J. Meyers, Vincent C. Marconi, Hamed Abedtash, et al. (+2)
18 [GO] 2022―Jun―30 Immune Persistence and Safety After SARS-CoV-2 BNT162b1 mRNA Vaccination in Chinese Adults: A Randomized, Placebo-Controlled, Double-Blind Phase 1 Trial Jingxin Li, Ai-Min Hui, Xiang Zhang, Lei Ge, Yuanzheng Qiu, Rong Tang, et al. (+24)
19 [GO] 2022―May―04 Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study Xiaoyan Yang, Qian Fan, Yue Zhang, Xiaoqin Chen, Yanglin Jiang, Haohan Zou, et al. (+3)
20 [GO] 2022―Apr―13 Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial Michael Dreher, Christian Grohè, Niels-Ulrik Hartmann, Stephan Kanzler, Karin Kraft, Christoph Sarrazin, et al. (+10)
21 [GO] 2022―Mar―14 Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, et al. (+7)
22 [GO] 2022―Feb―14 Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic Monica Fletcher, Thys van der Molen, Warren Lenney, Isabelle Boucot, Bhumika Aggarwal, Emilio Pizzichini
23 [GO] 2022―Feb―12 Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, et al. (+3)
24 [GO] 2022―Jan―24 A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab Lucinda Villaescusa, Francisco Zaragozá, Irene Gayo-Abeleira, Cristina Zaragozá
25 [GO] 2022―Jan―06 Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, et al. (+7)
26 [GO] 2021―Dec―15 Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan Kuan-Yuan Chen, Kang-Yun Lee, Albert Qin, Ching-Shan Luo, Yun-Kai Yeh, Jing-Quan Zheng, et al. (+6)
27 [GO] 2021―Nov―24 The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, et al. (+3)
28 [GO] 2021―Nov―22 Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L. McCollam, et al. (+2)
29 [GO] 2021―Nov―18 Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
30 [GO] 2021―Oct―05 Inpatient Hospital Costs for COVID-19 Patients in the United States Robert L. Ohsfeldt, Casey Kar-Chan Choong, Patrick L. Mc Collam, Hamed Abedtash, Kari A. Kelton, Russel Burge
31 [GO] 2021―Sep―13 Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis Martin Bergman, Christopher D. Saffore, Katherine J. Kim, Pankaj A. Patel, Vishvas Garg, Si Xuan, Haley B. Naik
32 [GO] 2021―Aug―23 Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study Or Assouline, Eli Ben-Chetrit, Yigal Helviz, Ramzi Kurd, Marc Leone, Sharon Einav
33 [GO] 2021―Aug―11 Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey Ergun Oksuz, Simten Malhan, Mustafa Sait Gonen, Zekayi Kutlubay, Yilmaz Keskindemirci, James Jarrett, et al. (+5)
34 [GO] 2021―Jul―18 Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service Rebecca C. Robey, Katie Kemp, Philip Hayton, Dalia Mudawi, Ran Wang, Melanie Greaves, et al. (+4)
35 [GO] 2021―Jun―26 Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study Ali Rezaie, Gil Y. Melmed, Gabriela Leite, Ruchi Mathur, Will Takakura, Isabel Pedraza, et al. (+4)
36 [GO] 2021―Jun―12 Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain Alejandro Soriano, Rocío Montejano, José Sanz-Moreno, Juan Carlos Figueira, Santiago Grau, Robert Güerri-Fernández, et al. (+4)
37 [GO] 2021―Jun―04 Platelet Reactivity and Coagulation Markers in Patients with COVID-19 Adriadne J. Bertolin, Talia F. Dalçóquio, Rocío Salsoso, Remo H. de M. Furtado, Roberto Kalil-Filho, Ludhmila A. Hajjar, et al. (+12)
38 [GO] 2021―Jun―01 Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
39 [GO] 2021―May―07 A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US Wenhui Wei, Sumathi Sivapalasingam, Scott Mellis, Gregory P. Geba, Jessica J. Jalbert
40 [GO] 2021―Apr―14 Can Thoracic Ultrasound on Admission Predict the Outcome of Critically Ill Patients with SARS-CoV-2? A French Multi-Centric Ancillary Retrospective Study Gary Duclos, Florian Bazalguette, Bernard Allaouchiche, Neyla Mohammedi, Alexandre Lopez, Mathieu Gazon, et al. (+8)
41 [GO] 2021―Apr―01 Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem Massimo Cugno, Roberta Gualtierotti, Giovanni Casazza, Francesco Tafuri, Gabriele Ghigliazza, Adriana Torri, et al. (+3)
42 [GO] 2021―Mar―01 A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States Daniel Sheinson, Joseph Dang, Anuj Shah, Yang Meng, David Elsea, Stacey Kowal
43 [GO] 2021―Jan―18 Post Abortion Care and Management After Induced Abortion During the COVID-19 Pandemic: A Chinese Expert Consensus Yu Wang, Qing Yang
44 [GO] 2020―Dec―26 Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization Daniel M. Sheinson, William B. Wong, Caroline E. Solon, Mindy M. Cheng, Anuj Shah, David Elsea, Yang Meng
45 [GO] 2020―Oct―27 Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19 Joseph A. Lasky, Jyotsna Fuloria, Marion E. Morrison, Randall Lanier, Odin Naderer, Tom Brundage, Allen Melemed
46 [GO] 2020―Oct―12 Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study Jennie H. Best, Shalini V. Mohan, Amanda M. Kong, Krish Patel, John M. Pagel, Boris Ivanov, et al. (+4)
47 [GO] 2020―Aug―27 Preparing the Burns Unit to Accommodate Vaginal Delivery and Cesarean Section for Pregnant Women with COVID-19: A Successful Experience from Jordan Omar Altal, Diab Bani Hani, Abdelwahab Aleshawi, Ala”a Alhowary, Basil Obeidat, Majid Bani-Ata
48 [GO] 2020―Aug―18 Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review Noemi Güemes-Villahoz, Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Julián Garcia-Feijoo, Pedro Arriola-Villalobos, Jose María Martínez-de-la-Casa, et al. (+2)
49 [GO] 2020―Aug―18 Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review Kaushik Subramanian, Anuradha Nalli, Vinitha Senthil, Saurabh Jain, Aravind Nayak, Amit Bhat
50 [GO] 2020―Jul―06 Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
51 [GO] 2020―Jun―05 Dysfunctional Coagulation in COVID-19: From Cell to Bedside Jie Wang, Ardan M. Saguner, Jiaqi An, Yuye Ning, Yang Yan, Guoliang Li
52 [GO] 2020―Apr―29 Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action Zakir Khan, Yusuf Karataş, Hazir Rahman
53 [GO] 2020―Apr―01 Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air Giustino Varrassi
 [1] 

53 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec